Fatigue and herpesvirus latency in women newly diagnosed with breast cancer
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Fatigue is a notable clinical problem in cancer survivors, and understanding its pathophysiology is important. The current study sought to determine biomarkers of fatigue that exist before cancer treatment. Relationships between the expression of latent Epstein–Barr virus (EBV) and cytomegalovirus (CMV) and fatigue were examined in 158 women newly diagnosed with breast cancer or awaiting a positive diagnostic result. Higher CMV antibody titers, but not EBV antibody titers, were associated with a greater likelihood of being fatigued. Associations between fatigue and higher CMV antibody titers remained after controlling for alcohol use, smoking, comorbidities, depressive symptoms, age, BMI, cancer stage, and sleep problems. More sleep problems and higher levels of depressive symptoms were also associated with a greater likelihood of being fatigued. CMV antibody titers, but not EBV antibody titers, were associated with higher levels of C-reactive protein (CRP), but CRP was not associated with fatigue. When the cellular immune system is compromised, reactivation of latent herpesviruses may fuel chronic inflammatory responses. Prior work has suggested that fatigue may be related to inflammation and its associated sickness behaviors; accordingly, our findings may be tapping into this same physiological substrate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190
Self-citationInflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life.
Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.743 · Cited by 1,134 · cited 3×
“A “case categorical” variable has been commonly used in studies assessing the biological mechanisms underlying cancer-related fatigue (Bower, 2007; Bower et al., 2000; 2002; 2003; 2005a,b; 2007; 2006; 2009; Fagundes et al., 2011).”
BackgroundMethodInfluentialPsychosocial Modifiers of Immunocompetence in Medical Students
Kiecolt-Glaser, J. K., Garner, W., Speicher, C., Penn, G. M., Holliday, J., & Glaser, R. (1984) · Psychosomatic Medicine · doi:10.1097/00006842-198401000-00003 · Cited by 782
Self-citationQuality of life among long-term breast cancer survivors: A systematic review
Mols, F., Vingerhoets, A. J. J. M., Coebergh, J. W., & van de Poll-Franse, L. V. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.05.017 · Cited by 585 · cited 1×
“Breast cancer patients are confronted with many problems during cancer treatment and its aftermath that can affect their well-being (Mols et al., 2005; Reich et al., 2008).”
BackgroundSavard, M.-H., Savard, J., Simard, S., & Ivers, H. (2005) · Psycho-Oncology · doi:10.1002/pon.860 · Cited by 449
Depression, quality of life and breast cancer: a review of the literature
Reich, M., Lesur, A., & Perdrizet-Chevallier, C. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9706-5 · Cited by 442 · cited 1×
“Breast cancer patients are confronted with many problems during cancer treatment and its aftermath that can affect their well-being (Mols et al., 2005; Reich et al., 2008).”
BackgroundInflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer
Bower, J. E., Ganz, P. A., Tao, M. L., Hu, W., Belin, T. R., Sepah, S., Cole, S., & Aziz, N. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2584 · Cited by 315
Diurnal cortisol rhythm and fatigue in breast cancer survivors
Bower, J. E., Ganz, P. A., Dickerson, S. S., Petersen, L., Aziz, N., & Fahey, J. L. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.06.003 · Cited by 308
Roberts, E. T., Haan, M. N., Dowd, J. B., & Aiello, A. E. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq177 · Cited by 281 · cited 2×
“Higher CMV antibody titers were also associated with all-cause mortality, and this relationship was largely explained by elevated IL-6 and TNF-α (Roberts et al., 2010).”
BackgroundFatigue is the most important symptom for advanced cancer patients who have had chemotherapy
Butt, Z., Rosenbloom, S. K., Abernethy, A. P., Beaumont, J. L., Paul, D., Hampton, D., Jacobsen, P. B., Syrjala, K. L., Von Roenn, J. H., & Cella, D. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0036 · Cited by 195 · cited 1×
“Fatigue is a common problem among those treated for breast cancer, as well as long-term breast cancer survivors (Bower et al., 2006; Butt et al., 2008; Cleeland et al., 2003; Ganz et al., 2002; Jacobsen et al., 2007).”
Background
Cited by
Cancer-related fatigue—mechanisms, risk factors, and treatments
Bower, J. E. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.127 · Cited by 1,666
Bower, J. E., & Lamkin, D. M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.011 · Cited by 372
Loneliness predicts pain, depression, and fatigue: Understanding the role of immune dysregulation
Jaremka, L. M., Fagundes, C. P., Glaser, R., Bennett, J. M., Malarkey, W. B., & Kiecolt-Glaser, J. K. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.11.016 · Cited by 316
Self-citationThe biology of cancer-related fatigue: a review of the literature
Multinational Association of Supportive Care in Cancer Fatigue Study Group–Biomarker Working Group, Saligan, L. N., Olson, K., Filler, K., Larkin, D., Cramp, F., Sriram, Y., Escalante, C. P., del Giglio, A., Kober, K. M., et al. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2763-0 · Cited by 296
Bower, J. E., Greendale, G., Crosswell, A. D., Garet, D., Sternlieb, B., Ganz, P. A., Irwin, M. R., Olmstead, R., Arevalo, J., & Cole, S. W. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.019 · Cited by 283
“Fatigue is associated with elevated antibody titers to cytomegalovirus (CMV) in breast cancer patients (Fagundes et al., 2012), suggesting an association between latent viral reactivation (and possible increases in IFN signaling pathways) and cancer-related fatigue.”
Metadata
- Authors
- Fagundes, C. P., Glaser, R., Alfano, C. M., Bennett, J. M., Povoski, S. P., Lipari, A. M., Agnese, D. M., Yee, L. D., Carson, W. E., Farrar, W. B., Malarkey, W. B., & Kiecolt-Glaser, J. K.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 26
- Issue
- 3
- Pages
- 394-400
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W1983361723
- Cited by
- 44
- References
- 11
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.